Fairfield Market Research Biosensors for Point-of-Care Diagnostics Market Size | 2030

Biosensors for Point-of-Care Diagnostics Market

Global Biosensors for Point-of-Care Diagnostics Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Product, By Transducer, By Application, By End User, By Geographic Coverage and By Company)

Published Date: Jul 2023 | Format: | No. of Pages: 210

Industry: Medical Devices | Author Name: Sayali

Request Sample / Information

  

FAQ : Biosensors for Point-of-Care Diagnostics Market

The market is expected to surpass the valuation of US$22 Bn by the end of 2030.

Between 2023 and 2030, the market for biosensors for point-of-care diagnostics is poised to witness a CAGR of 8.5%.

Product-wise, molecular diagnostic biosensors are likely to gain prominence over others. Whereas by application, glucose monitoring will be the leading market segment.

Asia Pacific is expected to dominate the biosensors for the point-of-care diagnostics market.

Danaher Corporation, Bio-Rad Laboratories Inc., Zimmer & Peacock AS, Medtronic plc, Koninklijke Philips N.V., and Abbott Laboratories are some of the major companies steering the competitive landscape of the global biosensors for point-of-care diagnostics market.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services